TY - JOUR
T1 - Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart
AU - Clements-Jewery, H
AU - Hearse, D J
AU - Curtis, M J
PY - 2002
Y1 - 2002
N2 - 1 Ventricular fibrillation (VF) in conscious rats with coronary artery ligation occurs in two phases, before (phase 1) and after (phase 2) 90 min of ischaemia respectively. The mechanisms of phase 2 VF are not established. Interestingly, phase 2 VF is absent in isolated (denervated) buffer-perfused rat hearts. We investigated whether catecholamine supplementation (to mimic sympathetic drive) was sufficient to restore phase 2 VF in such hearts. 2 Isolated rat hearts (n=10 per group) underwent coronary ligation for 240 min. At 90 min, during a period of relative electrical stability, the perfusion solution was switched from standard (Krebs) to identical solution or Krebs containing catecholamines (313 nM noradrenaline and 75 nM adrenaline) with or without 10 muM trimazosin (an alpha(1)-adrenoceptor antagonist) or 10 muM atenolol (a beta(1)-adrenoceptor antagonist). 3 Although in all groups the incidence of phase 1 VF was high (80-100%), the temporal distribution of VF was monophasic, i.e. only one heart in one group developed phase 2 VF (P=NS). Other ventricular arrhythmias (e.g., tachycardia; VT) exhibited a similar temporal distribution. Nevertheless, haemodynamic changes confirmed sympathomimetic effects of catecholamines, e.g., heart rate was increased from 278 7 beats min(-1) in controls to 335+/-8 beats min(-1) (P
AB - 1 Ventricular fibrillation (VF) in conscious rats with coronary artery ligation occurs in two phases, before (phase 1) and after (phase 2) 90 min of ischaemia respectively. The mechanisms of phase 2 VF are not established. Interestingly, phase 2 VF is absent in isolated (denervated) buffer-perfused rat hearts. We investigated whether catecholamine supplementation (to mimic sympathetic drive) was sufficient to restore phase 2 VF in such hearts. 2 Isolated rat hearts (n=10 per group) underwent coronary ligation for 240 min. At 90 min, during a period of relative electrical stability, the perfusion solution was switched from standard (Krebs) to identical solution or Krebs containing catecholamines (313 nM noradrenaline and 75 nM adrenaline) with or without 10 muM trimazosin (an alpha(1)-adrenoceptor antagonist) or 10 muM atenolol (a beta(1)-adrenoceptor antagonist). 3 Although in all groups the incidence of phase 1 VF was high (80-100%), the temporal distribution of VF was monophasic, i.e. only one heart in one group developed phase 2 VF (P=NS). Other ventricular arrhythmias (e.g., tachycardia; VT) exhibited a similar temporal distribution. Nevertheless, haemodynamic changes confirmed sympathomimetic effects of catecholamines, e.g., heart rate was increased from 278 7 beats min(-1) in controls to 335+/-8 beats min(-1) (P
UR - http://www.scopus.com/inward/record.url?scp=0036181996&partnerID=8YFLogxK
U2 - 10.1038/sj.bjp.0704509
DO - 10.1038/sj.bjp.0704509
M3 - Article
SN - 1476-5381
VL - 135
SP - 807
EP - 815
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 3
ER -